Quercetin and metabolic syndrome: A review

Citations Over TimeTop 1% of 2021 papers

Abstract

Metabolic syndrome (MetS) is a complex of diseases that lead to mortality due to the development of cardiovascular problems. Quercetin, as an important flavonoid, has various properties such as decreasing blood pressure, anti-hyperlipidemia, anti-hyperglycemia, anti-oxidant, antiviral, anticancer, anti-inflammatory, anti-microbial, neuroprotective, and cardio-protective effects. In this review article, we collected original articles from different sources such as Google Scholar, Medline, Scopus, and Pubmed, which is related to the effect of quercetin on the improvement of the signs of MetS, including elevated glucose level, hyperlipidemia, obesity, and blood pressure. According to these data, quercetin may also have a role in the management of metabolic disorders via different mechanisms such as increasing adiponectin, decreasing leptin, anti-oxidant activity, reduction of insulin resistance, the elevation of insulin level, and blocking of calcium channel. We have attempted to make some recommendations on the quercetin application in patients. However, it needs to do further clinical trials and more investigations to show the real clinical value of quercetin on metabolic syndrome.

Related Papers

• Metabolic syndrome, insulin resistance and adiponectin level in patients with chronic hepatitis C.(2008)
• Adiponectin levels and its role in insulin resistance among adult women with metabolic syndrome.(2010)
• → Quercetin suppresses the hyperlipidemia induced by an atherogenic diet in mice(2008)4 cited
• → Abstract 3595: Inverse Association of Adiponectin with Insulin Resistance is Attenuated with the Escalation of Insulin Resistance: a Possible Finding of Adiponectin Resistance(2007)1 cited
• Investigation Progression on the Relationship between Adiponectin and Insulin Resistance(2011)